Published June 20, 2022 | Version 1.0.0
Virtual screening on Nsp16: screening of 1084 compounds in VeroE6-eGFP cells
- 1. Janssen Pharmaceutica NV
This report describes the most relevant results of virtually screening the Janssen Pharmaceutica compound collection for potential activity against SARS-CoV-2 Nsp16 and confirmation of potential hits in a VeroE6 cell-based anti-SARS-CoV-2 assay.